Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bachtler, Barbara (1) Bader, Michael Prof. Dr. (28) Bähring, Sylvia Dr. (7) Birchmeier, Walter Prof. Dr. (12) Birchmeier-Kohler, Carmen Prof. Dr. (16) Blankenstein, Thomas Prof. Dr. (17) Falcke, Martin Prof. Dr. (6) Fielitz, Jens Dr. (2) Gotthardt, Michael Prof. Dr. (5) Heinemann, Udo Prof. Dr. (3) Höpken, Uta Elisabeth PD Dr. (2) Hübner, Norbert Prof. Dr. (5) Ivics, Zoltan Dr. (5) Izsvak, Zsuzsanna Dr. (6) Janz, Martin Dr. (1) Jentsch, Thomas Prof. Dr. (26) Kammertöns, Thomas Dr. (3) Kempa, Stefan Dr. (1) Kettenmann, Helmut Prof. Dr. (23) Kettritz, Ralph Prof. Dr. (6) Klußmann, Enno PD Dr. (3) Kühn, Ralf Dr. (5) Lee, Young-Ae Prof. Dr. (7) Leutz, Achim Prof. Dr. (5) Lewin, Gary Prof. Dr. (8) Luft, Friedrich Prof. Dr. (105) Mathas, Stephan Dr. (1) Morano, Ingo Prof. Dr. (16) Müller, Dominik Prof. Dr. (7) Niendorf, Thoralf Prof. Dr. (1) Ohler, Uwe Prof. Dr. (3) Pezzutto, Antonio Prof. Dr. (5) Pischon, Tobias Prof. Dr. (2) Rahn, Hans-Peter Dr. (2) Rajewsky, Klaus Prof. Dr. (2) Rajewsky, Nikolaus Prof. Dr. (3) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Saar, Kathrin Dr. (1) Sander, Maike Prof. Dr. (4) Scheidereit, Claus Prof. Dr. (10) Schlag, Peter M. Prof. Dr. (8) Schulz-Menger, Jeanette Prof. Dr. (5) Sporbert, Anje Dr. (2) Spuler, Simone Prof. (3) Stein, Ulrike Prof. Dr. (15) von Kries, Jens Peter Dr. (1) Waiczies, Sonia PD Dr. (1) Wallukat, Gerd Dr. (2) Walther, Wolfgang Prof. Dr. (14) Wanker, Erich Prof. Dr. (9) Willimsky, Gerald Dr. (4) Willnow, Thomas Prof. Dr. (8) Wolf, Jana Prof. Dr. (4) (-) Dechend, Ralf Priv. Doz. (10) (-) Gerhardt, Holger Prof. Dr. (7) (-) Kocks, Christine Dr. (1) AG Müller/Dechend (ECRC) (5) Genom-Editierung & Krankheitsmodelle (1) Hypertonie-vermittelter Endorganschaden (5) Hypertonie bedingte Endorganschäden (5) Integrative Vaskuläre Biologie (7) Transgenics (1) 1994 (3) 1995 (2) 1996 (3) (-) 1997 (6) 1999 (7) (-) 2000 (12) 2001 (9) 2002 (15) 2003 (13) 2004 (12) 2005 (13) 2006 (8) 2007 (17) 2008 (29) 2009 (22) 2010 (12) 2011 (26) 2012 (25) 2013 (30) 2014 (33) 2015 (34) 2016 (33) 2017 (36) 2018 (30) 2019 (38) 2020 (30) 2021 (33) 2022 (34) 2023 (28) 2024 (7) 18 Ergebnisse: Active Filter: Dechend, Ralf Priv. Doz.Gerhardt, Holger Prof. Dr.Kocks, Christine Dr.19972000 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Dezember 1997 / J Am Coll Cardiol Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction D.C. Gulba P. Tanswell R. Dechend M. Sosada A. Weis J. Waigand F. Uhlich S. Hauck S. Jost W. Rafflenbeul P.R. Lichtlen R. Dietz 01. Januar 2000 / Hypertension NF-kappaB Inhibition Ameliorates Angiotensin II-Induced Inflammatory Damage in Rats D.N. Muller R. Dechend E.M.A. Mervaala J.K. Park F. Schmidt A. Fiebeler J. Theuer V. Breu D. Ganten H. Haller F.C. Luft 01. Januar 2000 / Hypertension Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes E. Mervaala D.N. Mueller J.K. Park R. Dechend F. Schmidt A. Fiebeler M. Bieringer V. Breu D. Ganten H. Haller F.C. Luft 01. August 1997 / Fibrinolysis Update on the toxicology and pharmacology of rDSPA alpha 1 (Bat-PA) in animals and humans D.C. Gulba M. Praus R. Dechend S. Hauck M. Mahler R. Zitvz B. Baldus W. Mueller R. Dietz 23. Mai 2000 / Circulation AT1 receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor R. Dechend V. Homuth G. Wallukat J. Kreuzer J.K. Park J. Theuer A. Juepner D.C. Gulba N. Mackman H. Haller F.C. Luft 01. Juli 2000 / Am J Pathol Angiotensin II (AT1) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy D.N. Mueller E.M.A. Mervaala R. Dechend A. Fiebeler J.K. Park F. Schmidt J. Theuer V. Breu N. Mackman T. Luther W. Schneider D. Gulba D. Ganten H. Haller F.C. Luft 01. August 2000 / Hypertension Effect of Bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage D.N. Muller E.M.A. Mervaala F. Schmidt J.K. Park R. Dechend E. Genersch V. Breu B.M. Loeffler D. Ganten W. Schneider H. Haller F.C. Luft 01. November 1997 / J Mol Med B-Myb, a repressed trans-activating protein S. Ansieau E. Kowenz-Leutz R. Dechend A. Leutz 01. Oktober 2000 / Kidney Int Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects J.K. Park D.N. Mueller E.M.A. Mervaala R. Dechend A. Fiebeler F. Schmidt M. Bieringer O. Schaefer C. Lindschau W. Schneider D. Ganten F.C. Luft H. Haller 01. Januar 1997 / AJR Am J Roentgenol Stent implantation in patients with superior vena cava syndrome C.M. Gross J. Kraemer J. Waigand F. Uhlich G. Schroeder C. Thalhammer R. Dechend D. Gulba R. Dietz Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Dezember 1997 / J Am Coll Cardiol Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction D.C. Gulba P. Tanswell R. Dechend M. Sosada A. Weis J. Waigand F. Uhlich S. Hauck S. Jost W. Rafflenbeul P.R. Lichtlen R. Dietz
01. Januar 2000 / Hypertension NF-kappaB Inhibition Ameliorates Angiotensin II-Induced Inflammatory Damage in Rats D.N. Muller R. Dechend E.M.A. Mervaala J.K. Park F. Schmidt A. Fiebeler J. Theuer V. Breu D. Ganten H. Haller F.C. Luft
01. Januar 2000 / Hypertension Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes E. Mervaala D.N. Mueller J.K. Park R. Dechend F. Schmidt A. Fiebeler M. Bieringer V. Breu D. Ganten H. Haller F.C. Luft
01. August 1997 / Fibrinolysis Update on the toxicology and pharmacology of rDSPA alpha 1 (Bat-PA) in animals and humans D.C. Gulba M. Praus R. Dechend S. Hauck M. Mahler R. Zitvz B. Baldus W. Mueller R. Dietz
23. Mai 2000 / Circulation AT1 receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor R. Dechend V. Homuth G. Wallukat J. Kreuzer J.K. Park J. Theuer A. Juepner D.C. Gulba N. Mackman H. Haller F.C. Luft
01. Juli 2000 / Am J Pathol Angiotensin II (AT1) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy D.N. Mueller E.M.A. Mervaala R. Dechend A. Fiebeler J.K. Park F. Schmidt J. Theuer V. Breu N. Mackman T. Luther W. Schneider D. Gulba D. Ganten H. Haller F.C. Luft
01. August 2000 / Hypertension Effect of Bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage D.N. Muller E.M.A. Mervaala F. Schmidt J.K. Park R. Dechend E. Genersch V. Breu B.M. Loeffler D. Ganten W. Schneider H. Haller F.C. Luft
01. November 1997 / J Mol Med B-Myb, a repressed trans-activating protein S. Ansieau E. Kowenz-Leutz R. Dechend A. Leutz
01. Oktober 2000 / Kidney Int Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects J.K. Park D.N. Mueller E.M.A. Mervaala R. Dechend A. Fiebeler F. Schmidt M. Bieringer O. Schaefer C. Lindschau W. Schneider D. Ganten F.C. Luft H. Haller
01. Januar 1997 / AJR Am J Roentgenol Stent implantation in patients with superior vena cava syndrome C.M. Gross J. Kraemer J. Waigand F. Uhlich G. Schroeder C. Thalhammer R. Dechend D. Gulba R. Dietz